Richard C. Pfenninger's most recent trade in Cocrystal Pharma Inc was a trade of 16,410 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on Jan. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cocrystal Pharma Inc | Richard C. Pfenninger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 16,410 | 16,410 | - | - | Stock Options (Right to Buy) |